scispace - formally typeset
A

Alisdair Ryding

Researcher at Norfolk and Norwich University Hospital

Publications -  35
Citations -  698

Alisdair Ryding is an academic researcher from Norfolk and Norwich University Hospital. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 8, co-authored 24 publications receiving 518 citations. Previous affiliations of Alisdair Ryding include University of East Anglia & Westmead Hospital.

Papers
More filters
Journal ArticleDOI

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

Derek J. Hausenloy, +581 more
- 19 Oct 2019 - 
TL;DR: Remote ischaemic conditioning does not improve clinical outcomes at 12 months in patients with STEMI undergoing PPCI, and the primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 years in the intention-to-treat population.
Journal ArticleDOI

Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

TL;DR: Elevated BNP and NT-proBNP levels identify patients undergoing major noncardiac surgery at high risk of cardiac mortality, all-cause mortality, and MACE.
Journal ArticleDOI

The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP)

TL;DR: While survival benefit from more intensive management reduced with older age, better survival was associated with intensive management at all ages highlighting the requirement to improve standard of care in older patients with ACS.
Journal ArticleDOI

Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials

TL;DR: 3 to 6 months of DAPT following second generation DES and above is safe with no increased risk of thrombotic complications and mortality, and lower bleeding risk, however a tailored approach may be more appropriate for high-risk patients.